Frank McCormick

Frank McCormick has an estimated net worth of $128 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., BridgeBio Pharma, Inc., ADURO BIOTECH, INC., Olema Pharmaceuticals, Inc., and BridgeBio Oncology Therapeutics, Inc..

2019 was Frank McCormick's most active year for acquiring shares with 6 total transactions. Frank McCormick's most active month to acquire stocks was the month of April. 2019 was Frank McCormick's most active year for disposing of shares, totalling 16 transactions. Frank McCormick's most active month to dispose stocks was the month of November. 2025 saw Frank McCormick paying a total of $882,080.00 for 180,090 shares, this is the most they've acquired in one year. In 2025 Frank McCormick cashed out on 484,000 shares for a total of $21,669,536.69, their largest year based on trade value.